SARS-CoV-2 S1 (RBD) Lambda C.37 (Peru), GFP/His-Tag citations This mutation seems to have

This mutation seems to have no significant impact on the clinical spectrum of disease and not more transmissible than Delta

Omicron variant BA

RefSeq Links: UniProt: P01137

including macrophages

Test Cleavage

SARS-CoV-2 S1 (RBD) Lambda C.37 (Peru), GFP/His-Tag citations This mutation seems to haveRecombinant protein of the receptor binding domain (RBD), Mutant (L452Q F490S) of SARS CoV 2 (COVID 2019) Spike S1 from Wuhan pneumonia virus with C terminal His GFP Tag. The mutations L452Q F490S are characteristic for the SARS CoV 2 virus variant C. 37 emerged in South America (Peru) in late 2020. C. 37 is classified as Variant of Interest (VOI) and also known as Lambda variant. The mutations are affecting the receptor binding domain (RBD) of the